Oratie Karin de Visser ‘Het immuunsysteem is een tweesnijdend zwaard’


Karin De Visser, Working On Threat Famous artists, Artist at work, Studio

KARIN DE VISSER OUR RESEARCH Inflammation and cancer. Metastasis formation and unresponsiveness to conventional therapies are the challenges in cancer patient care that urgently need solutions. The overall goal of our research is to gain novel mechanistic insights into how the immune system influences these processes, with a primary focus on.


Karin de Visser Twentyfour Seven

Karin E. de Visser Nature Reviews Immunology 20 , 483-497 ( 2020) Cite this article 20k Accesses 205 Citations 108 Altmetric Metrics Abstract Metastatic disease is responsible for.


Rotterdam Contemporary Art Fair 2017

Karin de Visser Professor by special appointment Tumor Immunology Name Prof.dr. K.E. de Visser E-mail [email protected] Overview Profile Contact Publications Ancillary activities


Karin de Visser, kunstenaar van de maand augustus 2021 » Art & Jazz

Karin E. de Visser's research while affiliated with Netherlands Cancer Institute and other places Overview What is this page? This page lists the scientific contributions of an author, who.


Projectleider Karin Visser vertelt hoe de regio Amsterdam de subsidieaanvraag aanpakt Babyconnect

In February Karin de Visser received a VICI grant from NWO to investigate how genetic changes in breast cancer cells influence the immune system of patients. De Visser's research group is also affiliated with the Oncode Institute.


exto.nl City Blues van Karin de Visser

Seth B Coffelt 1 , Max D Wellenstein 1 , Karin E de Visser 1 Affiliation 1 Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. PMID: 27282249 DOI: 10.1038/nrc.2016.52 Abstract Neutrophils are indispensable antagonists of microbial infection and facilitators of wound healing..


exto.nl Encagement met Don Satijn1 van Karin de Visser

Karin de Visser Inflammation and cancer Metastasis formation and unresponsiveness to conventional therapies are the challenges in cancer patient care that urgently need solutions. The overall goal of our research is to gain novel mechanistic insights into how the immune system influences these processes, with a primary focus on breast cancer.


Karin de Visser Suspension

Karina Elizabeth de Visser (Karin de Visser, 1975), [1] also named "Karin E. de Visser", is a researcher at the Netherlands Cancer Institute. Her research considers metastatic formation and how the immune system influences how people respond to cancer treatment. Early life and education


Effectieve immunotherapie tegen borstkanker KWF Kankerbestrijding

Karin de Visser @deVisserKarin Tumor Immunologist @NKI_nl @oncodeinstitute interested in crosstalk between the immune system and breast cancer, metastasis, myeloid and adaptive immune cells Amsterdam, The Netherlandsnki.nl/research/resea… Joined December 2022 40Following 397Followers Tweets Tweets & replies Media Likes Karin de Visser's Tweets


Even voorstellen, Karin de Visser Alkmaars Kanaal

Prof. dr. Karin E. de Visser is group leader at the Division of Tumor Biology & Immunology at the Netherlands Cancer Institute, alongside her appointment as group leader at Oncode Institute and as full professor of Experimental Immunobiology of Cancer at Leiden University. The overall goal of her research is to dissect how the immune system influences metastatic breast cancer.


Birgit Speulman Karin de Visser Birgit Speulman

615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA Telephone: Email: Karin E. de Visser is a member of the Tumor Microenvironment Working Group Steering Committee.


Inaugural lecture Karin de Visser Oncode Institute

Seth B Coffelt 1 , Karin E de Visser 1 Affiliation 1 Division of Immunology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. PMID: 24572360 DOI: 10.1038/nature13062 No abstract available. Publication types Comment MeSH terms.


De Visser, Karin, PhD TRR332 neutrophils

Hannah Garner 1 , Karin E de Visser 2 3 Affiliations 1 Division of Tumour Biology & Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands.. Leiden University Medical Centre, Leiden, Netherlands. [email protected]. PMID: 32024984 DOI: 10.1038/s41577-019-0271-z Abstract.


Karin de Visser YouTube

Karin E de Visser Netherlands Cancer Institute · Division of Immunology PhD Connect with experts in your field Join ResearchGate to contact this researcher and connect with your scientific.


Karin Visser directeur Toezicht en Opsporing bij ILT Nieuwsbericht Algemene Bestuursdienst

KARIN DE VISSER OUR RESOURCES Resources. Our team has developed a preclinical mouse model of invasive lobular breast cancer metastasis. We used this model to unravel mammary tumor-induced pro-metastatic inflammation (IL-17-producing γδ T cells and.


Oratie Karin de Visser ‘Het immuunsysteem is een tweesnijdend zwaard’

Karin E de Visser 1 , Johanna A Joyce 2 Affiliations 1 Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands. Electronic address: [email protected].

Scroll to Top